Free Trial

GAMMA Investing LLC Increases Holdings in Genpact Limited (NYSE:G)

Genpact logo with Business Services background

GAMMA Investing LLC lifted its position in Genpact Limited (NYSE:G - Free Report) by 9,371.4% in the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 490,903 shares of the business services provider's stock after acquiring an additional 485,720 shares during the period. GAMMA Investing LLC owned 0.28% of Genpact worth $24,732,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds also recently made changes to their positions in the company. Coppell Advisory Solutions LLC grew its holdings in Genpact by 529.5% in the fourth quarter. Coppell Advisory Solutions LLC now owns 598 shares of the business services provider's stock worth $25,000 after purchasing an additional 503 shares during the period. SRH Advisors LLC bought a new stake in shares of Genpact in the 4th quarter worth approximately $26,000. Atlas Capital Advisors Inc. grew its stake in shares of Genpact by 55.8% in the 4th quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after buying an additional 216 shares during the last quarter. Manchester Capital Management LLC bought a new position in Genpact during the 4th quarter valued at approximately $38,000. Finally, GeoWealth Management LLC increased its position in Genpact by 199.0% during the 4th quarter. GeoWealth Management LLC now owns 876 shares of the business services provider's stock valued at $38,000 after buying an additional 583 shares in the last quarter. Hedge funds and other institutional investors own 96.03% of the company's stock.

Genpact Stock Performance

Shares of NYSE:G traded up $0.99 during midday trading on Friday, reaching $43.09. 1,606,953 shares of the company's stock traded hands, compared to its average volume of 1,374,726. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. Genpact Limited has a one year low of $30.38 and a one year high of $56.76. The company has a market cap of $7.54 billion, a price-to-earnings ratio of 15.17, a P/E/G ratio of 1.84 and a beta of 1.02. The stock has a 50 day moving average of $46.13 and a 200 day moving average of $47.22.

Genpact (NYSE:G - Get Free Report) last issued its earnings results on Wednesday, May 7th. The business services provider reported $0.84 earnings per share for the quarter, topping analysts' consensus estimates of $0.80 by $0.04. The business had revenue of $1.21 billion during the quarter, compared to analyst estimates of $1.21 billion. Genpact had a return on equity of 22.50% and a net margin of 10.77%. Genpact's revenue was up 7.4% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.73 EPS. As a group, equities research analysts anticipate that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Shareholders of record on Wednesday, June 18th will be given a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.58%. Genpact's dividend payout ratio (DPR) is presently 23.21%.

Insiders Place Their Bets

In related news, CEO Balkrishan Kalra sold 13,600 shares of the business's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the transaction, the chief executive officer now directly owns 310,246 shares in the company, valued at approximately $15,167,926.94. The trade was a 4.20% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Nicholas C. Gangestad purchased 2,000 shares of the company's stock in a transaction on Tuesday, May 13th. The stock was purchased at an average price of $43.97 per share, with a total value of $87,940.00. Following the completion of the transaction, the director now owns 2,000 shares of the company's stock, valued at approximately $87,940. This trade represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. 3.07% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

G has been the topic of several analyst reports. Mizuho boosted their target price on Genpact from $45.00 to $55.00 and gave the stock a "neutral" rating in a report on Monday, February 10th. Robert W. Baird lowered their price target on Genpact from $56.00 to $50.00 and set a "neutral" rating for the company in a research report on Thursday, May 8th. TD Cowen raised shares of Genpact from a "hold" rating to a "buy" rating and increased their price objective for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Finally, Needham & Company LLC reduced their price objective on shares of Genpact from $55.00 to $50.00 and set a "buy" rating for the company in a research note on Thursday, May 8th. Four analysts have rated the stock with a hold rating and three have issued a buy rating to the company's stock. According to MarketBeat, Genpact has a consensus rating of "Hold" and an average target price of $50.71.

Get Our Latest Research Report on G

Genpact Company Profile

(Free Report)

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.

Featured Articles

Institutional Ownership by Quarter for Genpact (NYSE:G)

Should You Invest $1,000 in Genpact Right Now?

Before you consider Genpact, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Genpact wasn't on the list.

While Genpact currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Goldman Sachs Warns of 20% Market Drop—Are They Right?
3 Bank Stocks Defying Market Turmoil—Cheap Options Trades!
Massive Buybacks: 3 Stocks Insiders Are Buying Up

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines